Safety Notices

From time to time notices relating to the safety and/or quality of medicinal products are published by the Health Products Regulatory Authority

These notices are classified under several priority related categories and may relate to human and veterinary medicines, or medical devices.   

The issues covered by these notices will range from quality defect information and medicinal product safety information through to updated information on the appropriate usage of medicines or devices.

Notices are categorised in accordance with their importance at time of publication.

The four notice categories are outlined as follows:

  • Advisory  -  Routine safety information            
  • Warning  -  Urgent safety information
  • Recall  -  Urgent safety information relating to a product recall
  • Publications  -  General safety information provided by the HPRA for publication via 3rd parties e.g. MIMS

The HPRA Drug Safety Newsletter is also published on a regular basis.

Date Title Type
16/09/2020 Medicinal Product Shortages - update - 16 September 2020 Advisory
14/09/2020 HPRA IMF Article September 2020 3rd Party Publications
09/09/2020 Medicinal Product Shortages - update - 09 September 2020 Advisory
07/09/2020 Murexal 10mg/ml - Important Safety Information from Laboratoire Aguettant as approved by the HPRA 3rd Party Publications
04/09/2020 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 3rd Party Publications
03/09/2020 Medicinal Product Shortages - update - 03 September 2020 Advisory
28/08/2020 Modafinil - Important Safety Information from Bluefish Pharmaceuticals as approved by HPRA 3rd Party Publications
26/08/2020 Medicinal Product Shortages - update - 26 August 2020 Advisory
19/08/2020 Medicinal Product Shortages - update - 19 August 2020 Advisory
17/08/2020 HPRA MIMS Articles July and August 2020 3rd Party Publications